A Phase 1 Dose Escalation Study of Bortezomib Combined With Rituximab, Cyclophosphamide, Doxorubicin, Modified Vincristine, and Prednisone for Untreated Follicular Lymphoma and Other Low-Grade B-Cell LymphomasSINHA, Rajni; KAUFMAN, Jonathan L; JO LECHOWICZ, Mary et al.Cancer. 2012, Vol 118, Num 14, pp 3538-3548, issn 0008-543X, 11 p.Article

A Phase 1 Dose-Escalation Study of ARRY-520, a Kinesin Spindle Protein Inhibitor, in Patients With Advanced Myeloid LeukemiasJEAN KHOURY, Hanna; GARCIA-MANERO, Guillermo; KARAN, Sharon et al.Cancer. 2012, Vol 118, Num 14, pp 3556-3564, issn 0008-543X, 9 p.Article